These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 23383547)

  • 1. [Modern methods for diagnosis and therapy of lupus nephritis].
    Zdrojewski Z
    Ann Acad Med Stetin; 2011; 57(3):39-48. PubMed ID: 23383547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Laboratory and morphologic parameters in patients with lupus nephritis].
    Rasković S; Bogić M; Perić-Popadić A; Stefanović L; Arandjelović S; Jovicić Z; Bolpacić J; Tomić-Spirić V
    Srp Arh Celok Lek; 2002 Aug; 130 Suppl 3():38-41. PubMed ID: 12583312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Significance of serum anti-Clq Ab in evaluation of lupus nephritis activity and its curative effects of pharmacotherapy on lupus nephritis].
    Cai XY; Yang XY; Chen XH; Liang LQ; Guan MM; Qin SG; Fu JZ
    Zhonghua Yi Xue Za Zhi; 2004 Sep; 84(17):1436-9. PubMed ID: 15500738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomarkers for lupus nephritis: a critical appraisal.
    Mok CC
    J Biomed Biotechnol; 2010; 2010():638413. PubMed ID: 20414362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement.
    Oelzner P; Deliyska B; Fünfstück R; Hein G; Herrmann D; Stein G
    Clin Rheumatol; 2003 Oct; 22(4-5):271-8. PubMed ID: 14576989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lupus nephritis: pathophysiology, diagnosis, and collaborative management.
    Smith DM; Fortune-Faulkner EM; Spurbeck BL
    Nephrol Nurs J; 2000 Apr; 27(2):199-204, 209-11. PubMed ID: 11111547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal outcome and predictors of clinical renal involvement in patients with silent lupus nephritis.
    Wada Y; Ito S; Ueno M; Nakano M; Arakawa M; Gejyo F
    Nephron Clin Pract; 2004; 98(4):c105-11. PubMed ID: 15627787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum albumin as a marker for disease activity in patients with systemic lupus erythematosus.
    Yip J; Aghdassi E; Su J; Lou W; Reich H; Bargman J; Scholey J; Gladman DD; Urowitz MB; Fortin PR
    J Rheumatol; 2010 Aug; 37(8):1667-72. PubMed ID: 20516026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment options in lupus nephritis.
    McLigeyo SO
    East Afr Med J; 1998 Oct; 75(10):609-13. PubMed ID: 10065198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary proteomic profiles distinguish between active and inactive lupus nephritis.
    Mosley K; Tam FW; Edwards RJ; Crozier J; Pusey CD; Lightstone L
    Rheumatology (Oxford); 2006 Dec; 45(12):1497-504. PubMed ID: 17046860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Lupus nephritis].
    Melderis S; Wiech T; Iking-Konert C; Steinmetz OM
    Z Rheumatol; 2018 Sep; 77(7):593-608. PubMed ID: 29955955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lupus nephritis.
    Singh S; Saxena R
    Am J Med Sci; 2009 Jun; 337(6):451-60. PubMed ID: 19390431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-C1q antibodies in nephritis: correlation between titres and renal disease activity and positive predictive value in systemic lupus erythematosus.
    Marto N; Bertolaccini ML; Calabuig E; Hughes GR; Khamashta MA
    Ann Rheum Dis; 2005 Mar; 64(3):444-8. PubMed ID: 15286009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lupus nephritis in children--a review of 167 patients.
    Yang LY; Chen WP; Lin CY
    Pediatrics; 1994 Sep; 94(3):335-40. PubMed ID: 8065859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical approach to lupus nephritis: recent advances.
    Molino C; Fabbian F; Longhini C
    Eur J Intern Med; 2009 Sep; 20(5):447-53. PubMed ID: 19712841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Previous antimalarial therapy in patients diagnosed with lupus nephritis: influence on outcomes and survival.
    Sisó A; Ramos-Casals M; Bové A; Brito-Zerón P; Soria N; Muñoz S; Testi A; Plaza J; Sentís J; Coca A
    Lupus; 2008 Apr; 17(4):281-8. PubMed ID: 18413408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urine sVCAM-1 and sICAM-1 levels are elevated in lupus nephritis.
    Howe HS; Kong KO; Thong BY; Law WG; Chia FL; Lian TY; Lau TC; Chng HH; Leung BP
    Int J Rheum Dis; 2012 Feb; 15(1):13-6. PubMed ID: 22324942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are laboratory tests useful for monitoring the activity of lupus nephritis? A 6-year prospective study in a cohort of 228 patients with lupus nephritis.
    Moroni G; Radice A; Giammarresi G; Quaglini S; Gallelli B; Leoni A; Li Vecchi M; Messa P; Sinico RA
    Ann Rheum Dis; 2009 Feb; 68(2):234-7. PubMed ID: 18718989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of cytokines as biomarkers in systemic lupus erythematosus and lupus nephritis.
    Adhya Z; Borozdenkova S; Karim MY
    Nephrol Dial Transplant; 2011 Oct; 26(10):3273-80. PubMed ID: 21372259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-neutrophil cytoplasmic antibodies (ANCA) in systemic lupus erythematosus: prevalence, clinical associations and correlation with other autoantibodies.
    Pradhan VD; Badakere SS; Bichile LS; Almeida AF
    J Assoc Physicians India; 2004 Jul; 52():533-7. PubMed ID: 15645975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.